Literature DB >> 12922103

Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus.

Jeng-Hwan Wang1, Chi-Ming Liang, Jei-Ming Peng, Jeng-Jer Shieh, Ming-Hwa Jong, Yeou-Liang Lin, Martin Sieber, Shu-Mei Liang.   

Abstract

VP1, a capsid protein of foot-and-mouth disease virus (FMDV), contains neutralizing epitopes of the virus. Due to its poor water solubility, recombinant Escherichia coli derived VP1 (rVP1) has previously been used mainly in a denatured form and is not well characterized. Here, using SDS to assist protein refolding and then removing SDS with a detergent removing column, we have successfully purified rVP1 in two aqueous-soluble forms, i.e. monomer and dimer. Studies showed that dimerization occurs by an inter-molecular disulfide bond between two cysteine residues at position 187 of each monomer. Heat treatment revealed that rVP1 dimer exhibited a more thermal-stable conformation than the monomeric form. Both monomeric and dimeric rVP1 reacted with anti-FMDV antibodies. Immunization studies demonstrated that vaccination of swine with either forms of rVP1 was effective in generating immune responses and protecting them from viral challenge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12922103     DOI: 10.1016/s0264-410x(03)00363-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Serological evidence of human klassevirus infection.

Authors:  Alexander L Greninger; Lori Holtz; Gagandeep Kang; Donald Ganem; David Wang; Joseph L DeRisi
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

2.  Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice.

Authors:  Ji-Young Bae; Sun-Hwa Moon; Jung-Ah Choi; Jong-Sug Park; Bum-Soo Hahn; Ki-Yong Kim; Byunghan Kim; Jae-Young Song; Dae-Hyuck Kwon; Suk-Chan Lee; Jong-Bum Kim; Joo-Sung Yang
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

3.  Cultivation and serological characterization of a human Theiler's-like cardiovirus associated with diarrheal disease.

Authors:  C Y Chiu; A L Greninger; E C Chen; T D Haggerty; J Parsonnet; E Delwart; J L Derisi; D Ganem
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

4.  Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production.

Authors:  Tai-An Chen; Jui-Ling Wang; Shao-Wen Hung; Chiao-Li Chu; Yung-Chih Cheng; Shu-Mei Liang
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

5.  Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.

Authors:  Ho-Bin Lee; Da-Chuan Piao; Jun-Yeong Lee; Jae-Yun Choi; Jin-Duck Bok; Chong-Su Cho; Sang-Kee Kang; Yun-Jaie Choi
Journal:  Microb Cell Fact       Date:  2017-02-22       Impact factor: 5.328

6.  Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus.

Authors:  Ning-Sun Yang; Jeng-Hwan Wang; Ku-Feng Lin; Chien-Yu Wang; Suk-Am Kim; Yu-Ling Yang; Ming-Hwa Jong; Tsun-Yung Kuo; Shiow-Suey Lai; R Holland Cheng; Ming-Tsair Chan; Shu-Mei Liang
Journal:  J Gene Med       Date:  2005-06       Impact factor: 4.565

7.  Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate.

Authors:  Hyang-Sim Lee; Sun-Young Park; Ah-Young Kim; Sang-Oh Lee; Jae-Seok Kim; Hyejin Kim; Hee-Jeong Youn; Young-Joon Ko
Journal:  J Vet Med Sci       Date:  2020-07-23       Impact factor: 1.267

8.  Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli.

Authors:  Chien-Der Lee; Yao-Pei Yan; Shu-Mei Liang; Ting-Fang Wang
Journal:  J Biomed Sci       Date:  2009-08-11       Impact factor: 8.410

9.  Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes.

Authors:  Chung-Da Yang; Jia-Teh Liao; Chen-Yen Lai; Ming-Hwa Jong; Chi-Ming Liang; Yeou-Liang Lin; Na-Sheng Lin; Yau-Heiu Hsu; Shu-Mei Liang
Journal:  BMC Biotechnol       Date:  2007-09-27       Impact factor: 2.563

10.  Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7.

Authors:  Ming-Yi Ho; Shao-Wen Hung; Chi-Ming Liang; Shu-Mei Liang
Journal:  Oncotarget       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.